Prostate Cancer Therapeutics Market Size Worth $12.0 Billion By 2025 Prostate Cancer Therapeutics Market | страница 3

•
•
•
North America dominated the global market. Rising prevalence and mortality rate
associated with such tumors in the U.S. is the primary reason for the dominance
of the region.
Asia Pacific is anticipated to be the fastest growing region over the forecast period.
Rising awareness regarding prostate cancer in Asian countries including China,
Japan, & India, would be the major factor driving the growth.
Some of the major players include, but are not limited to, Johnson & Johnson;
Astella, Inc.; Sanofi; Ipsen; Bayer AG; AstraZeneca; Valeant Pharmaceuticals
North America LLC (Dendreon Corporation). These major players dominate the
market owing to their strong brand identity and extensive geographic reach.
Read our blog on healthcare industry:
http://www.grandviewresearch.com/blogs/healthcare
Table of content of global prostate cancer therapeutics market research report:
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 List of Data Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Prostate Cancer Therapeutics Market Variables, Trends & Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.1.1 Rising rate of prostate cancer cases
Follow Us: